Bioventus annual gross margin
2019
2020
2021
2022
2023
2024
2025
Bioventus Gross Margin Growth & History (BVS)
Bioventus's gross margin was 68.33% for fiscal 2025.
View full Bioventus company overviewBioventus annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 68.33% | +0.61 pp |
| 2024 | 2024-12-31 | 67.72% | +3.66 pp |
| 2023 | 2023-12-31 | 64.06% | −0.59 pp |
| 2022 | 2022-12-31 | 64.65% | −5.60 pp |
| 2021 | 2021-12-31 | 70.25% | −2.46 pp |
| 2020 | 2020-12-31 | 72.71% | −0.55 pp |
| 2019 | 2019-12-31 | 73.27% | — |
Bioventus quarterly gross margin
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-27 | 68.97% | −0.17 pp |
| Q1 2026 | 2026-03-28 | 68.72% | +1.67 pp |
| Q4 2025 | 2025-12-31 | 68.89% | +2.08 pp |
| Q3 2025 | 2025-09-27 | 67.96% | +0.64 pp |
| Q2 2025 | 2025-06-28 | 69.14% | +0.60 pp |
| Q1 2025 | 2025-03-29 | 67.05% | −1.22 pp |
| Q4 2024 | 2024-12-31 | 66.82% | +3.09 pp |
| Q3 2024 | 2024-09-28 | 67.32% | +2.04 pp |
| Q2 2024 | 2024-06-29 | 68.54% | +3.52 pp |
| Q1 2024 | 2024-03-30 | 68.27% | +6.18 pp |
| Q4 2023 | 2023-12-31 | 63.73% | +4.77 pp |
| Q3 2023 | 2023-09-30 | 65.28% | −0.43 pp |
| Q2 2023 | 2023-07-01 | 65.02% | −3.86 pp |
| Q1 2023 | 2023-04-01 | 62.09% | −2.46 pp |
| Q4 2022 | 2022-12-31 | 58.96% | −8.34 pp |
| Q3 2022 | 2022-10-01 | 65.70% | −6.91 pp |
| Q2 2022 | 2022-07-02 | 68.88% | −0.62 pp |
| Q1 2022 | 2022-04-02 | 64.54% | −8.28 pp |
| Q4 2021 | 2021-12-31 | 67.30% | −7.22 pp |
| Q3 2021 | 2021-10-02 | 72.61% | −0.10 pp |
| Q2 2021 | 2021-07-03 | 69.49% | −0.06 pp |
| Q1 2021 | 2021-04-03 | 72.83% | +0.05 pp |
| Q4 2020 | 2020-12-31 | 74.52% | — |
| Q3 2020 | 2020-09-26 | 72.71% | — |
| Q2 2020 | 2020-06-27 | 69.55% | — |
| Q1 2020 | 2020-03-28 | 72.78% | — |
Bioventus gross margin trends
Over the last five reported fiscal years, Bioventus's gross margin decreased from 72.71% to 68.33%, a change of −4.38 percentage points. The latest reported quarter, Q2 2026, shows 68.97%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus filings at SEC.gov ↗